We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
AILERON Therapeutics.
- Authors
Sawyer, Tomi K.
- Abstract
The article profiles AILERON Therapeutics Inc., the biopharmaceutical company in Cambridge, Massachusetts. It notes that the company produces revolutionary class of drugs called Stapled Peptides which has the ability to deal with currently undruggable therapeutic targets and promises clinical applications for human diseases. Moreover, Stapled Peptides address intracellular and extracellular protein-protein interactions that act as critical control points in disease mechanism.
- Subjects
CAMBRIDGE (Mass.); MASSACHUSETTS; AILERON Therapeutics Inc.; PEPTIDES; PROTEIN-protein interactions; THERAPEUTIC equivalency in drugs; THERAPEUTICS
- Publication
Chemical Biology & Drug Design, 2009, Vol 73, Issue 1, p3
- ISSN
1747-0277
- Publication type
Other
- DOI
10.1111/j.1747-0285.2008.00744.x